American journal of medical genetics. Part A · 2023
Jansen-de Vries syndrome: Expansion of the PPM1D clinical and phenotypic spectrum in 34 families.
СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wojcik Monica H, Srivastava Siddharth, Agrawal Pankaj B, Balci Tugce B, Callewaert Bert, Calvo Pier Luigi, Carli Diana, Caudle Michelle, Colaiacovo Samantha, Cross Laura, Demetriou Kalliope, Drazba Katy, Dutra-Clarke Marina, Edwards Matthew, Genetti Casie A, Grange Dorothy K, Hickey Scott E, Isidor Bertrand, Küry Sébastien, Lachman Herbert M, Lavillaureix Alinoe, Lyons Michael J, Marcelis Carlo, Marco Elysa J, Martinez-Agosto Julian A, Nowak Catherine, Pizzol Antonio, Planes Marc, Prijoles Eloise J, Riberi Evelise, Rush Eric T, Russell Bianca E, Sachdev Rani, Schmalz Betsy, Shears Deborah, Stevenson David A, Wilson Kate, Jansen Sandra, de Vries Bert B A, Curry Cynthia J
Аннотация
Jansen-de Vries syndrome (JdVS) is a neurodevelopmental condition attributed to pathogenic variants in Exons 5 and 6 of PPM1D. As the full phenotypic spectrum and natural history remain to be defined, we describe a large cohort of children and adults with JdVS. This is a retrospective cohort study of 37 individuals from 34 families with disease-causing variants in PPM1D leading to JdVS. Clinical data were provided by treating physicians and/or families. Of the 37 individuals, 27 were male and 10 female, with median age 8.75 years (range 8 months to 62 years). Four families document autosomal dominant transmission, and 32/34 probands were diagnosed via exome sequencing. The facial gestalt, including a broad forehead and broad mouth with a thin and tented upper lip, was most recognizable between 18 and 48 months of age. Common manifestations included global developmental delay (35/36, 97%), hypotonia (25/34, 74%), short stature (14/33, 42%), constipation (22/31, 71%), and cyclic vomiting (6/35, 17%). Distinctive personality traits include a hypersocial affect (21/31, 68%) and moderate-to-severe anxiety (18/28, 64%). In conclusion, JdVS is a clinically recognizable neurodevelopmental syndrome with a characteristic personality and distinctive facial features. The association of pathogenic variants in PPM1D with cyclic vomiting bears not only medical attention but also further pathogenic and mechanistic evaluation.